(Press-News.org) Contact information: Arantxa Mena
amena@idibell.cat
34-932-607-282
IDIBELL-Bellvitge Biomedical Research Institute
Why tumors become resistant to chemotherapy?
IDIBELL Researchers describe epigenetic changes that explain the lack of response to drugs in colon cancer
A common observation in oncology is the phenomenon that a patient with a tumor receives a drug and responds very well, but after a few months the cancer comes back and is now resistant to previously administered chemotherapy. What happened? Many mechanisms contribute to explain this effect called "acquired resistance", but today the group Manel Esteller, Director of Epigenetics and Cancer Biology at the Bellvitge Biomedical Research Institute (IDIBELL) , ICREA researcher and Professor of Genetics at the University of Barcelona, describes in the official Journal of the National Cancer Research Center in the United States , The Journal of The National Cancer Institute, the existence of epigenetic differences that explain the lack of response of the tumor recurs.
"We studied colon cancer cells that were initially sensitive to oxaliplatin drug and then became insensitive to this drug and we found that resistant tumors had inactivated a gene (SRBC) in their DNA" says Manel Esteller "the loss of activity supposedly happens in a gene involved in DNA repair. Thus these tumor cells, when receiving the drug, quickly repair the effect thereof and do not die. Studying nearly two hundred patients with colon cancer also found that inactivation of the gene is associated with poorer survival of these people despite treatment. Interestingly the loss of function of this gene could also explain why some colon tumors are resistant from the outset, what is known as "primary resistance " concludes Esteller.
The discovery could have important implications for personalized treatment of colon cancer. If these findings extend to other clinical trials, determining the activation state of the SRBC gene could be useful in deciding whether a patient should receive a type of drug or another. Likewise the use of another class of drugs that return gen activity (epigenetic drugs) could restore the sensitivity to the original drug , oxaliplatin .
Finally, a very promising door is opened to examine whether similar mechanisms are happening in other human tumors beyond colon cancer.
INFORMATION:
Article reference
Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer. Moutinho C, Martinez-Cardús A, Santos C, Navarro-Pérez V, Martínez-Balibrea E, Musulen E, Carmona FJ, Sartore-Bianchi A, Cassingena A, Siena S, Elez E, Tabernero J, Salazar R, Abad A, Esteller M. The Journal of the National Cancer Institute, PMID: 24273214, 2013.
Why tumors become resistant to chemotherapy?
IDIBELL Researchers describe epigenetic changes that explain the lack of response to drugs in colon cancer
2013-12-02
ELSE PRESS RELEASES FROM THIS DATE:
Crossing continents -- where we drive affects how we drive
2013-12-02
Crossing continents -- where we drive affects how we drive
According to the International Transport Forum Malaysia has one of the highest death rates from road traffic accidents in the world. While the number of road deaths continues to rise in ...
CNIO scientists create the first large catalog of interactions between drugs and proteins
2013-12-02
CNIO scientists create the first large catalog of interactions between drugs and proteins
The catalog will serve to provide a reference tool for modern molecular pharmacology and for the study of the consequences of mutations in cancer
The three-dimensional ...
Researchers identify genetic fingerprints of endangered conifers
2013-12-02
Researchers identify genetic fingerprints of endangered conifers
The world's largest Podocarpaceae collection in Bochum
In the tropics and subtropics, many evergreen conifers are endangered. Biologists at the Ruhr-Universität Bochum (RUB) have ...
The heart's own stem cells play their part in regeneration
2013-12-02
The heart's own stem cells play their part in regeneration
Sca1 stem cells replace steadily aging heart muscle cells
This news release is available in German. Up until a few years ago, the common school of thought held that the mammalian heart ...
Researchers pinpoint superbug resistance protein
2013-12-02
Researchers pinpoint superbug resistance protein
Researchers have identified a resistance protein that allows bacteria to survive chlorhexidine, a disinfectant commonly used in wipes, cleansers and mouthwashes in hospitals.
A study led jointly ...
Snapshots differentiate molecules from their mirror image
2013-12-02
Snapshots differentiate molecules from their mirror image
Max Planck researchers are able to reveal the spatial structure of chiral molecules
This news release is available in German. Small difference, large effect: Most biological molecules ...
Junk food and poor oral health increase risk of premature heart disease
2013-12-02
Junk food and poor oral health increase risk of premature heart disease
The association between poor oral health and increased risk of cardiovascular disease should make the reduction of sugars such as those contained in junk food, particularly fizzy drinks, an important ...
How a legless, leaping fish that lives on land avoids predators
2013-12-02
How a legless, leaping fish that lives on land avoids predators
SYDNEY: One of the world's strangest animals – a legless, leaping fish that lives on land - uses camouflage to avoid attacks by predators such as birds, lizards and crabs, new research ...
Telescope to track space junk using youth radio station
2013-12-02
Telescope to track space junk using youth radio station
Inaugural results reveal enormous potential of SKA precursor
A combination of pop songs, talkback radio and cutting-edge science has enabled Australian astronomers to identify ...
Mild hypothermia as a treatment for CNS injuries: Positive or negative effects?
2013-12-02
Mild hypothermia as a treatment for CNS injuries: Positive or negative effects?
There are few data on the effectiveness and mechanism underlying mild hypothermia in the treatment of central nervous system injuries. Therefore, there is a need to investigate the potentially ...
LAST 30 PRESS RELEASES:
Cooler heads prevail: New research reveals best way to prevent dogs from overheating
UC Riverside medical school develops new curriculum to address substance use crisis
Food fussiness a largely genetic trait from toddlerhood to adolescence
Celebrating a century of scholarship: Isis examines the HSS at 100
Key biomarkers identified for predicting disability progression in multiple sclerosis
Study: AI could lead to inconsistent outcomes in home surveillance
Study: Networks of Beliefs theory integrates internal & external dynamics
Vegans’ intake of protein and essential amino acids is adequate but ultra-processed products are also needed
Major $21 million Australian philanthropic investment to bring future science into disease diagnosis
Innovating alloy production: A single step from ores to sustainable metals
New combination treatment brings hope to patients with advanced bladder cancer
Grants for $3.5M from TARCC fund new Alzheimer’s disease research at UTHealth Houston
UTIA researchers win grant for automation technology for nursery industry
Can captive tigers be part of the effort to save wild populations?
The Ocean Corporation collaborates with UTHealth Houston on Space Medicine Fellowship program
Mysteries of the bizarre ‘pseudogap’ in quantum physics finally untangled
Study: Proteins in tooth enamel offer window into human wellness
New cancer cachexia treatment boosts weight gain and patient activity
Rensselaer researcher receives $3 million grant to explore gut health
Elam named as a Fellow of the Electrochemical Society
Study reveals gaps in access to long-term contraceptive supplies
Shining a light on the roots of plant “intelligence”
Scientists identify a unique combination of bacterial strains that could treat antibiotic-resistant gut infections
Pushing kidney-stone fragments reduces stones’ recurrence
Sweet success: genomic insights into the wax apple's flavor and fertility
New study charts how Earth’s global temperature has drastically changed over the past 485 million years, driven by carbon dioxide
Scientists say we have enough evidence to agree global action on microplastics
485 million-year temperature record of Earth reveals Phanerozoic climate variability
Atmospheric blocking slows ocean-driven glacier melt in Greenland
Study: Over nearly half a billion years, Earth’s global temperature has changed drastically, driven by carbon dioxide
[Press-News.org] Why tumors become resistant to chemotherapy?IDIBELL Researchers describe epigenetic changes that explain the lack of response to drugs in colon cancer